Catalyst Wire Dossier Catalyst Wire Dossier

Celsentri

maraviroc · ViiV Healthcare B.V.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Celsentri, covering 2010-02-10 to 2026-01-12. Get the full timeline:

Most recent: EMA Authorised: Celsentri (maraviroc) — ViiV Healthcare B.V.

See pricing